Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
Sulagna Bhattacharya

Message the company or request a 1:1 meeting here

Nanoscope Therapeutics Inc. is a clinical-stage biopharmaceutical company advancing optogenetics platform for restoring vision in patients with retinal degenerations by reprogramming the surviving retinal neurons to be photosensitive. The Gene-agnostic Optogenetics platform Focuses on disease phenotype instead of a specific genotypic deficit and allows treatment of disease caused by many different mutations.

Pitch Video

Executive Summary